And there are some worries about side-effects (nausea, diarrhoea, vomiting, and constipation), and safety concerns (as with any new drug) which need to be dealt with before it becomes certified for use
Arterial blood pressure variability and other vascular factors contribution to the cognitive decline in Parkinsons disease
In this context, glucagon-like peptide-2 (GLP-2) and its sister molecule glucagon-like peptide-1 (GLP-1) are of particular interest, as being critically involved in hepatic lipid homeostasis 5,6
The Effect of a Low-FODMAP Diet on Quality of Life, Severity of Symptoms and Leaky Gut in Patients with Irritable Bowel Syndrome
Self-report and spot checks don't generate the kind of continuous, objective data that clinical development, pharmacovigilance, and patient support programs actually need